Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland W Sutter

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
JAMA|October 14, 2004
Vaccine policy changes and epidemiology of poliomyelitis in the United StatesLorraine Niño Alexander, Jane F Seward, Tammy A Santibanez, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Vaccine|October 11, 2021
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemicNatalia A Molodecky, Hamid Jafari, Rana M Safdar, et al.
Vaccine|July 21, 2015
Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicitySonia Resik, Alina Tejeda, Ondrej Mach, et al.
Vaccine|March 8, 2018
Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017Imtiaz Hussain, Ondrej Mach, Nasir A Hamid, et al.
The Lancet. Infectious Diseases|June 22, 2015
Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trialFatima Mir, Farheen Quadri, Ondrej Mach, et al.
Plos One|January 6, 2016
Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to PoliovirusAyan Dey, Natalie A Molodecky, Harish Verma, et al.
The Lancet. Microbe|September 29, 2023
Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trialArun K Sharma, Harish Verma, Concepcion F Estivariz, et al.
Lancet (London, England)|October 29, 2010
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialRoland W Sutter, T Jacob John, Hemant Jain, et al.
The Journal of Infectious Diseases|October 16, 2014
Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern IndiaSunil Bahl, Concepción F Estívariz, Roland W Sutter, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
JAMA|October 14, 2004
Vaccine policy changes and epidemiology of poliomyelitis in the United StatesLorraine Niño Alexander, Jane F Seward, Tammy A Santibanez, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Vaccine|October 11, 2021
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemicNatalia A Molodecky, Hamid Jafari, Rana M Safdar, et al.
Vaccine|July 21, 2015
Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicitySonia Resik, Alina Tejeda, Ondrej Mach, et al.
Vaccine|March 8, 2018
Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017Imtiaz Hussain, Ondrej Mach, Nasir A Hamid, et al.
The Lancet. Infectious Diseases|June 22, 2015
Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trialFatima Mir, Farheen Quadri, Ondrej Mach, et al.
Plos One|January 6, 2016
Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to PoliovirusAyan Dey, Natalie A Molodecky, Harish Verma, et al.
The Lancet. Microbe|September 29, 2023
Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trialArun K Sharma, Harish Verma, Concepcion F Estivariz, et al.
Lancet (London, England)|October 29, 2010
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialRoland W Sutter, T Jacob John, Hemant Jain, et al.
The Journal of Infectious Diseases|October 16, 2014
Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern IndiaSunil Bahl, Concepción F Estívariz, Roland W Sutter, et al.
Pageof 13